Claritev CTEV 深 沪
已收盘 10-09 16:00:00 美东时间
24.66
+0.330
+1.36%
华盛通- 最 高25.33
- 今 开24.51
- 成交量 12.68万股
- 最 低 24.51
- 昨 收 24.33
- 总市值 4.18亿
- 52周最高 73.68
- 市盈率 静 --
- 换手率 0.75%
- 52周最低 11.50
- 委 比 99.34%
- 总股本 1694.75万
- 历史最高 74.0699
- 量 比 0.57
- 振 幅 3.37%
- 历史最低 0.173
- 每 手 1
- 风险率 13.27%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Claritev Selected By General Dynamics Information Technology To Support The World Trade Center Health Program; Terms Not Disclosed
The WTC Health Program is a limited federal health care program established under the James Zadroga 9/11 Health and Compensation Act of 2010 (Extended in 2015). It provides nationwide medical monitoring and treatment to responders and survivors of the events of September 11, 2001. As part of GDIT’s ...
09-22 21:03
又一“最大”，335亿出售
来源：器械之家，未经授权不得转载，且24小时后方可转载 近日，据路透社报道，全球顶级私募股权投资机构TPG（德太投资）正在评估出售旗下医疗保健软件公司Lyr...
09-19 19:12
Claritev Adds AI Expert Ben Letham to Board
The latest announcement is out from Claritev ( ($CTEV) ). On September 14, 2026...
09-15 21:59
传私募股权TPG(TPG.US)拟出售医疗保健软件公司Lyric 估值或达50亿美元
据知情人士透露，私募股权TPG(TPG.US)正在探索出售医疗保健行业软件公司Lyric。知情人士表示，该公司每年产生约2.5亿美元的息税折旧摊销前利润(EB...
09-10 10:30
美股大行评级 | 罗斯百货、迪尔股份获多家大行上调目标价；沃尔玛、Advance遭多家大行下调目标价
今日重点评级关注：摩根士丹利：维持Ultragenyx Pharmaceutical"超配"评级，目标价从67美元升至74美元；Truist Securities：维持Solid Biosciences"买入"评级，目标价从16美元升至20美元
08-24 16:40
Barclays Maintains Overweight on Claritev, Raises Price Target to $40
Barclays analyst Glen Santangelo maintains Claritev (NYSE:CTEV) with a Overweight and raises the price target from $28 to $40.
08-21 23:05
Claritev Expands Collaboration With Marpai To Launch Pre, Post- Payment Integrity Services To Health Plans
Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company, today announced that Marpai, Inc. (OTCQX:MRAI) has expanded its relationship with Claritev to bring comprehensive pre- and post-payment integrity capabilities to the health plans and claims it administers.
08-17 21:05
Saudi Arabia's PIF adds Elon Musk's SpaceX in Q2
Saudi Arabia's sovereign wealth fund, PIF, initiated a new position in Elon Musk's Space Exploration Technologies (SPCX) during the second quarter. One of the largest and most impactful state funds, P...
08-15 00:04
美股大行评级 | 业绩大超预期！ CoreWeave、超微电脑、Lumentum绩后获多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从49美元升至56美元；韦德布什：维持Zura Bio"跑赢大市"评级，目标价从15美元升至22美元
08-13 11:44
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
